Business Description
Clover Health Investments Corp
NAICS : 525120
SIC : 6324
ISIN : US18914F1030
Share Class Description:
CLOV: Ordinary Shares - Class ADescription
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 52.05 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1.91 | |||||
| Beneish M-Score | -3.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36.3 | |||||
| 3-Year EBITDA Growth Rate | -30.9 | |||||
| 3-Year EPS without NRI Growth Rate | -0.5 | |||||
| 3-Year FCF Growth Rate | 6.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.99 | |||||
| 9-Day RSI | 50.66 | |||||
| 14-Day RSI | 43.67 | |||||
| 6-1 Month Momentum % | -17.81 | |||||
| 12-1 Month Momentum % | 7.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.64 | |||||
| Cash Ratio | 0.93 | |||||
| Days Payable | 7.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.5 | |||||
| Shareholder Yield % | 6.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.65 | |||||
| Operating Margin % | -9.07 | |||||
| Net Margin % | -10.49 | |||||
| FCF Margin % | -5.73 | |||||
| ROE % | -65.9 | |||||
| ROA % | -20.71 | |||||
| ROIC % | -28.96 | |||||
| ROC (Joel Greenblatt) % | -2448.18 | |||||
| ROCE % | -61.98 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.16 | |||||
| PB Ratio | 1.14 | |||||
| Price-to-Tangible-Book | 1.16 | |||||
| EV-to-EBIT | -0.46 | |||||
| EV-to-Forward-EBIT | -0.02 | |||||
| EV-to-EBITDA | -0.47 | |||||
| EV-to-Forward-EBITDA | -0.76 | |||||
| EV-to-Revenue | 0.05 | |||||
| EV-to-Forward-Revenue | 0.08 | |||||
| EV-to-FCF | -0.85 | |||||
| Price-to-Net-Current-Asset-Value | 2.33 | |||||
| Earnings Yield (Greenblatt) % | -217.39 | |||||
| FCF Yield % | -34.83 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers